{"contacts": [{"terms": [{"accession": "MS:1000586", "name": "contact name", "value": "Dennis Goldfarb"}, {"accession": "MS:1000589", "name": "contact email", "value": "dennisg@email.unc.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Cell and Developmental Biology"}, {"accession": "MS:1002037", "name": "dataset submitter"}]}, {"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Ben Major"}, {"accession": "MS:1000589", "name": "contact email", "value": "ben_major@med.unc.edu"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Department of Cell Biology and Physiology Lineberger  Comprehensive Cancer Center  University of North Carolina at Chapel Hill  450 West Drive  Lineberger Building CB#7295  Chapel Hill, NC, 27599, USA.  Telephone: (919)-259-2695."}]}], "datasetFiles": [{"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/abemaciclib_TMT_dose_response_rep1_cells.zip"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/abemaciclib_TMT_dose_response_rep2_cells.zip"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/DB_TMT_abemaciclib.zip"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/H2228_drug_treatment_LFQ.zip"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/H2228_lysate_abemaciclib_TMT.zip"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/human_KinaseAnnot.txt"}, {"accession": "PRIDE:0000403", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/human_sp_072313.fasta"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1373_H2228_DMSO_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1375_H2228_DMSO_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1377_H2228_DMSO_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1400_H2228_Trametinib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1401_H2228_BMS777607_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1402_H2228_Dasatinib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1403_H2228_Palbociclib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1404_H2228_abemaciclib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1405_H2228_Trametinib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1406_H2228_BMS777607_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1407_H2228_Dasatinib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1408_H2228_Palbociclib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1409_H2228_abemaciclib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1410_H2228_Trametinib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1411_H2228_BMS777607_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1412_H2228_Dasatinib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1414_H2228_abemaciclib_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1542_JR1030_DMSO_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1543_JR1031_DMSO_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1544_JR1032_DMSO_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1546_JR1034_DMSO_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1547_JR1045_GSK212_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1548_JR1046_GSK212_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1549_JR1047_GSK212_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1550_JR1048_GSK212_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1551_JR1337_GSK212_mouse_kidney_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1589_H2228_abemaciclib_dose_response_TMT_MIBMS_Emily.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1603_H2228_abemaciclib_dose_response_TMT_MIBMS_Emily_30B.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1747_DB_abema_dose_response_TMT_MIBMS_EMC.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1748_DB_abema_dose_response_TMT_MIBMS_EMC.raw"}, {"accession": "PRIDE:0000404", "name": "Associated raw file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/MA1751_H2228_abema_dose_response_10plex_MIBMS_EMC.raw"}, {"accession": "PRIDE:0000410", "name": "'Other' type file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/mouseKinaseAnnot.tab"}, {"accession": "PRIDE:0000408", "name": "Search engine output file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/mouse_kidney_trametinib.zip"}, {"accession": "PRIDE:0000403", "name": "Associated file URI", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139/Uniprot_Mouse_Proteome_03052015.fasta"}], "description": "The cellular and organismal phenotypic response to a small molecule kinase inhibitor is defined collectively by the inhibitor\u2019s targets and their functions. The selectively of small molecule kinase inhibitors is commonly determined in vitro, using purified kinases and substrates. Recently, competitive chemical proteomics has emerged as a complementary, unbiased, cell-based approach to define the target landscape of kinase inhibitors. Here we evaluated and optimized a competitive multiplexed inhibitor bead mass spectrometry (MIB/MS) platform using cell lysates, live cells and treated mice.  Several clinically active kinase inhibitors were profiled, including trametinib, BMS-777607, dasatinib, abemaciclib, and palbociclib. MIB/MS competition analyses of the cyclin-dependent kinase 4 and 6 (CDK4/6) inhibitors abemaciclib, and palbociclib revealed overlapping and unique kinase targets. Competitive MIB/MS analysis of abemaciclib revealed 83 target kinases, and dose-response profiling revealed glycogen synthase kinase 3 alpha and beta (GSK3\uf061 and GSK3\uf062\uf029 were the most potently inhibited. Cell based and in vitro kinase assays show that in contrast to palbociclib, abemaciclib directly inhibits (GSK3\uf061/\u03b2) kinase activity at low nanomolar concentrations.  Consequently, abemaciclib activates \u03b2-catenin-dependent WNT signaling, as determined by \u03b2-catenin transcriptional activation and \u03b2-catenin protein stabilization. These data reveal differential kinase target specificities for CDK4/6 inhibitors may help explain differential clinical efficacy and dose-limiting toxicities. More broadly, we highlight the power of competitive chemical proteomics to identify multiple targets of kinase inhibitors in protein lysate, treated cells and in treated mice.", "fullDatasetLinks": [{"accession": "PRIDE:0000411", "name": "Dataset FTP location", "value": "ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/12/PXD006139"}, {"accession": "MS:1001930", "name": "PRIDE project URI", "value": "http://www.ebi.ac.uk/pride/archive/projects/PXD006139"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD006139"}], "instruments": [{"accession": "MS:1002732", "name": "Orbitrap Fusion Lumos"}, {"accession": "MS:1001910", "name": "LTQ Orbitrap Elite"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "Kinase, chemoproteomics, GSK3\u03b2, WNT signaling, polypharmacology"}, {"accession": "MS:1001926", "name": "curator keyword", "value": "Biomedical"}], "modifications": [{"accession": "MOD:00696", "name": "phosphorylated residue"}, {"accession": "MOD:00425", "name": "monohydroxylated residue"}, {"accession": "MOD:00394", "name": "acetylated residue"}, {"accession": "MOD:00397", "name": "iodoacetamide derivatized residue"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "29133594"}, {"accession": "PRIDE:0000400", "name": "Reference", "value": "Cousins EM, Goldfarb D, Yan F, Roques J, Darr DB, Johnson GL, Major MB. Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits GSK3\u03b2 and Activates WNT Signaling. Mol Cancer Res. 2017"}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Mus musculus (Mouse)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10090"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens (Human)"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Competitive Kinase Enrichment Proteomics Reveals that Abemaciclib Inhibits Glycogen Synthase Kinase 3 Beta and Activates WNT Signaling"}